Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company... see more

TSXV:MPH - Post Discussion

Medicure Inc > Will this be just another Bert Friesen Failure?
View:
Post by pholover on Aug 07, 2024 11:30pm

Will this be just another Bert Friesen Failure?

His original idea with this drug for Heart Surgery just did not last long enough in the bloodstream to work. It is not likely he will fail here too? ..His whole career has been stuff that has not worked or Companies that lost a ton of money all while he took out a ton of cash personally through egregious salaries or  related Companies as he is doing with Medicure
Comment by Whalewatcher1 on Sep 09, 2024 10:44pm
Hey Pholover, How does this board allow Bert to continue his self serving?  Bert’s Medicure MC-1 fails, so he uses one of his personally owned holding company to file patents on next generation MC-1. Then turns around and convinces board to agree in acquiring those patients for $100k upfront and $500k for filing an IND and tens of millions in additional milestones, plus royalty that goes ...more  
Comment by pholover on Sep 22, 2024 12:33am
Very insightful post Whalewatcher.  I have heard that it has been brought to the attention of more than one Director.  Self dealing/filing patents using a related Company in this case is utterly shameful and shows the lack of character with Friesen who has a Rolls Royce while he has lost tens of millions of dollars for his shareholders, takes a salary that is 75% of the CEO salary for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities